Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.

导出 OA

翻译打印收藏纠错

作者： Mei,Gao ^[1] ; Miranda,Lin ^[2] ; Richard A,Moffitt ^[1] ; Marcela A,Salazar ^[3] ; Jinha,Park ^[4] ; Jeffrey,Vacirca ^[5] ; Chuan,Huang ^[6] ; Kenneth R,Shroyer ^[7] ; Minsig,Choi ^[8] ; Georgios V,Georgakis ^[3] ; Aaron R,Sasson ^[9] ; Mark A,Talamini ^[10] ; Joseph,Kim ^[10]

作者单位： Department of Surgery, University of Kentucky, Lexington, KY, USA. ^[1] Markey Cancer Center, University of Kentucky, Lexington, KY, USA. ^[2] Department of Pathology, State University of New York, Stony Brook, NY, USA. ^[3] Department of Experimental Therapeutics, City of Hope, Duarte, CA, USA. ^[4] Department of Radiology, University of Iowa, Iowa City, IA, USA. ^[5] New York Cancer Specialists, East Setauket, New York, NY, USA. ^[6] Departments of Radiology, State University of New York, Stony Brook, NY, USA. ^[7] Departments of Psychiatry, State University of New York, Stony Brook, NY, USA. ^[8] Departments of Medicine, State University of New York, Stony Brook, NY, USA. ^[9] Departments of Surgery, State University of New York, Stony Brook, NY, USA. ^[10] Department of Surgery, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com. ^[11] Markey Cancer Center, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com. ^[12]